Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jason Miller

Podiatrist, Foot & Ankle Surgery Malvern, PA Doctor of Podiatric Medicine

NPI 1225023138 CMS profile 327680

266 Lancaster Ave, Suite 200, Malvern, PA 19355

Open in the dashboard

General payments

$500,887

747 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$27,052

1 holding reported · through program year 2025

Research they led as principal investigator

$22,724 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Jason Miller of Malvern, PA is reported in the CMS Open Payments database as having received $500,887 across 747 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $22,724 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $27,052 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $87,144 188
2024 General $54,569 101
2023 General $80,714 105
2022 General $78,494 99
2021 General $55,739 55
2020 General $51,346 58
2019 General $92,882 141
2025 Ownership $27,052 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jason Miller
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Jason Miller were reported at $87,144. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Jason Miller Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $92,882 $389 $118–$1,406 $163
2020 $51,346 $191 $62–$691 $114
2021 $55,739 $329 $104–$1,341 $132
2022 $78,494 $419 $125–$1,611 $149
2023 $80,714 $377 $128–$1,164 $160
2024 $54,569 $394 $134–$1,168 $164
2025 $87,144 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $160,482 62 payments
  2. Treace Medical Concepts, Inc. $121,583 114 payments
  3. Bioventus LLC $61,233 125 payments
  4. Stryker Corporation $42,700 75 payments
  5. Alexion Pharmaceuticals, Inc. $24,650 56 payments
  6. Kerecis Limited $22,921 16 payments
  7. restor3d, inc. $21,332 18 payments
  8. Acumed LLC $14,650 24 payments
  9. Integra LifeSciences Corporation $7,904 15 payments
  10. Biocomposites Inc $5,345 9 payments
  11. Other $18,088 233 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $174,804 66 payments
  2. Royalty or License $149,724 27 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $80,674 46 payments
  4. Travel and Lodging $50,546 174 payments
  5. Food and Beverage $25,983 425 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $13,500 3 payments
  7. Honoraria $4,840 4 payments
  8. Gift $816 2 payments
Products named General payments · program years 2019–2025
  1. AccuPort Knee Creations $72,730 8 payments
  2. LAPIPLASTY SYSTEM Foot And Ankle $70,666 53 payments
  3. EXOGEN ULTRASOUND BONE HEALING SYSTEM $58,734 109 payments
  4. Lapiplasty System Y $35,634 42 payments
  5. AccuPort Knee Creations $34,792 4 payments
  6. ORTHOLOC 2 LAPIFUSE $25,616 18 payments
  7. AccuPort Knee Creations $18,878 3 payments
  8. Kerecis Omega3 SurgiClose $17,387 9 payments
  9. PROSTEP $16,616 16 payments
  10. AccuFill $16,560 28 payments
  11. Other $331,931 646 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

103

Median for Podiatry: 160

Drug cost

$2,830

Median for Podiatry: $2,368

Branded share of claims

10.7%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Doxycycline Hyclate Generic 21 $1,527
Celecoxib Generic 45 $1,115
Methylprednisolone Generic 12 $98
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 11 $64
Meloxicam Generic 14 $26

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 108 billing codes

Paid by Medicare

$158,242

Of which drugs: $4,307

Medicare patients

433

Average age 74

Services billed

2,758

290 women, 143 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 68%
Arthritis 64%
Ischemic heart disease 27%
Osteoporosis 23%
Diabetes 22%
Depression 20%
Chronic kidney disease 18%
Cancer 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 84 275 $1,511
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 60 321 $243

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

5 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Qutenza
  • Averitas Pharma Inc. $3,080
$3,080 — —
STRENSIQ
  • Alexion Pharmaceuticals, Inc. $648
$648 — —
Licart
  • IBSA Pharma Inc. $116
$116 — —
NUZYRA
  • Paratek Pharmaceuticals, Inc. $14
$14 — —
Tirosint
  • IBSA Pharma Inc. $12
$12 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

747 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record